Ponazuril, sold by the Bayer Corporation under the trade name Marquis, is a drug currently approved for the treatment of equine protozoal myeloencephalitis in horses, caused by Sarcocystis neurona. Its therapeutic use is listed as antiparasitics. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Marquis and Toltrazuril sulfone. Its PubChem CID is 3050408.
Ponazuril
| CAS No | 69004-04-2 |
|---|---|
| Molecular Formula | C18H14F3N3O6S |
| Molecular Weight | 457.4 g/mol |
| Synonyms | 1-methyl-3-[3-methyl-4-[4-(trifluoromethylsulfonyl)phenoxy]phenyl]-1,3,5-triazinane-2,4,6-trione |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Ponazuril, sold by the Bayer Corporation under the trade name Marquis, is a drug currently approved for the treatment of equine protozoal myeloencephalitis in horses, caused by Sarcocystis neurona.
The listed CAS number is 69004-04-2.
The listed molecular formula is C18H14F3N3O6S.
The listed molecular weight is 457.4 g/mol.
1-methyl-3-[3-methyl-4-[4-(trifluoromethylsulfonyl)phenoxy]phenyl]-1,3,5-triazinane-2,4,6-trione.
The source lists Marquis and Toltrazuril sulfone.